tiprankstipranks
Amicus Therapeutics (GB:0HF9)
LSE:0HF9
Holding GB:0HF9?
Track your performance easily

Amicus (0HF9) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Amicus Therapeutics’s (0HF9) Moving Averages Convergence Divergence (MACD) indicator is -0.21, suggesting Amicus Therapeutics is a Buy.
Amicus Therapeutics’s (0HF9) 20-Day exponential moving average is 9.63, while Amicus Therapeutics’s (0HF9) share price is $9.21, making it a Sell.
Amicus Therapeutics’s (0HF9) 50-Day exponential moving average is 10.00, while Amicus Therapeutics’s (0HF9) share price is $9.21, making it a Sell.

Amicus (0HF9) Pivot Points

Jan 10, 2025, 08:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.40
9.41
9.42
9.44
9.44
9.46
9.46
Fibonacci
9.41
9.42
9.43
9.44
9.44
9.45
9.46
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Amicus (0HF9) Moving Averages

Jan 10, 2025, 08:01 AM
Period
Simple
Exponential
MA5
9.37Sell
9.37Sell
MA10
9.49Sell
9.47Sell
MA20
9.69Sell
9.63Sell
MA50
10.11Sell
10.00Sell
MA100
10.65Sell
10.35Sell
MA200
10.50Sell
10.73Sell
Amicus Therapeutics’s (0HF9) 10-Day exponential moving average is 9.47, while Amicus Therapeutics’s (0HF9) share price is $9.21, making it a Sell.
Amicus Therapeutics’s (0HF9) 100-Day exponential moving average is 10.35, while Amicus Therapeutics’s (0HF9) share price is $9.21, making it a Sell.
Amicus Therapeutics’s (0HF9) stock price is $9.21 and Amicus Therapeutics’s (0HF9) 50-day simple moving average is 10.11, creating a Sell signal.
Amicus Therapeutics’s (0HF9) stock price is $9.21 and Amicus Therapeutics’s (0HF9) 100-day simple moving average is 10.65, creating a Sell signal.
Amicus Therapeutics’s (0HF9) stock price is $9.21 and Amicus Therapeutics’s (0HF9) 200-day simple moving average is 10.50, creating a Sell signal.

Amicus (0HF9) Technical Indicators

Jan 10, 2025, 08:01 AM
Name
Value
Implied Action
RSI (14)
37.09
Neutral
STOCH (9,6)
17.28
Buy
STOCHRSI (14)
13.75
Buy
MACD (12,26)
-0.21
Buy
ADX (14)
25.79
Neutral
Williams %R
-94.53
Buy
CCI (14)
-120.50
Buy
ATR (14)
0.22
-
Ultimate Oscillator
41.84
Neutral
ROC
-6.41
Sell
Amicus Therapeutics’s (0HF9) Relative Strength Index (RSI) is 37.09, creating a Neutral signal.
Amicus Therapeutics’s (0HF9) Trend Strength Indicator (ADX) is 25.79, creating a Neutral signal.
Amicus Therapeutics’s (0HF9) Commodity Channel Index (CCI) is -120.50, creating a Buy signal.
Amicus Therapeutics’s (0HF9) Price Rate of Change (ROC) is -6.41, creating a Sell signal.

FAQ

Is 0HF9 a Buy, Hold, or Sell?
Based on 0HF9’s technical indicators, 0HF9 is a Sell.
    What is 0HF9’s RSI (14)?
    0HF9’s RSI (14) is 37.09, which suggests 0HF9 is a Neutral.
      What is 0HF9’s MACD?
      0HF9’s MACD is -0.21, which suggests 0HF9 is a Buy.
        What is 0HF9’s 5-day moving average?
        0HF9’s 5-day moving average is 9.37, which suggests 0HF9 is a Sell.
          What is 0HF9’s 20-day moving average?
          0HF9 20-day moving average is 9.69, which suggests 0HF9 is a Sell.
            What is 0HF9’s 50-day moving average?
            0HF9’s 50-day moving average is 10.11, which suggests 0HF9 is a Sell.
              What is 0HF9’s 200-day moving average?
              0HF9’s 200-day moving average is 10.50, which suggests 0HF9 is a Sell.
                What is 0HF9’s Williams % R (14)?
                0HF9’s Williams % R (14) is -94.53, which suggests 0HF9 is a Buy.
                  What is 0HF9’s CCI (14)?
                  0HF9’s CCI (14) is -120.50, which suggests 0HF9 is a Buy.
                    What is the share price of Amicus Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis